Inventor · disambiguated record
Steven Perrin
Also filed as: PERRIN STEVEN · PERRIN STEVEN N
12 granted patents·4 pending applications·52 citations·filing 2009–2025
89Inventor score
Files withALS THERAPY DEVELOPMENT INST10ALS THERAPY DEV INST3PERRIN STEVEN2ELEDON PHARMACEUTICALS INC1
Top patents by PatentIndex Score
16 records- 0195US11692040B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2021·Granted Jul 4, 2023·4 cites·8 claims
- 0295US11014990B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2020·Granted May 25, 2021·6 cites·10 claims
- 0393US10683356B2Methods of treating a CD40L associated disease or disorder by administering anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2018·Granted Jun 16, 2020·8 cites·4 claims
- 0490US10106618B2Anti-CD40L antibodiesALS THERAPY DEVELOPMENT INST·Filed 2017·Granted Oct 23, 2018·8 cites·9 claims
- 0588US8435514B2Method for the treatment of neurodegenerative diseasesPERRIN STEVEN·Filed 2009·Granted May 7, 2013·17 cites·1 claims
- 0687US9044459B2Method for the treatment of neurodegenerative diseasesALS THERAPY DEV INST·Filed 2013·Granted Jun 2, 2015·8 cites·4 claims
- 0785US12275793B2Anti-CD40L antibodies and methods for treating CD40L-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2023·Granted Apr 15, 2025·0 cites·11 claims
- 0878US11708349B2Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditionsALS THERAPY DEVELOPMENT INST·Filed 2019·Granted Jul 25, 2023·1 cites·13 claims
- 0977US12157728B2Targeting of endoplasmic reticulum dysfunction and protein folding stress to treat neurological conditionsALS THERAPY DEVELOPMENT INST·Filed 2023·Granted Dec 3, 2024·0 cites·15 claims
- 1075US2025263493A1Anti-cd40l antibodies and methods for treating cd40l-related diseases or disordersALS THERAPY DEVELOPMENT INST·Filed 2025·Application pending·0 cites
- 1166US2024016879A1Copper complexes for treatment of neurodegenerative disordersALS THERAPY DEVELOPMENT INST·Filed 2023·Application pending·0 cites
- 1262US2025334594A1Methods for the treatment of amyotrophic lateral sclerosisELEDON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1361US11660324B2Copper complexes for treatment of neurodegenerative disordersALS THERAPY DEVELOPMENT INST·Filed 2020·Granted May 30, 2023·0 cites·14 claims
- 1454US8946301B2Targeting of T-lymphocytes to treat amyotrophic lateral sclerosisALS THERAPY DEV INST·Filed 2012·Granted Feb 3, 2015·0 cites·13 claims
- 1546US8673308B2Targeting of CD8+ T-lymphocytes to treat neurodegenerative diseasesPERRIN STEVEN·Filed 2012·Granted Mar 18, 2014·0 cites·17 claims
- 1637US2017231558A1Measurement Of ALS Progression Based On Kinetic DataALS THERAPY DEV INST·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Perrin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →